Pipeline
We are working to develop novel small molecule inhibitors of skeletal muscle-specific ClC-1 chloride ion channels that can be applied to a large range of indications, including several orphan diseases.
We are working to develop novel small molecule inhibitors of skeletal muscle-specific ClC-1 chloride ion channels that can be applied to a large range of indications, including several orphan diseases.
